United States: Desjardins Discusses Current Goals, Future Of Device Industry, And FDA Priorities For 2024 - Arnold & Porter
Thursday, 7 December 2023
Life Sciences & Healthcare Regulatory partner Philip Desjardins, who recently rejoined the firm, was profiled in the Medtech Insight article...
|
||||
You Might Like |
||||
